BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18628253)

  • 1. Sensitivity analysis of biologically motivated model for formaldehyde-induced respiratory cancer in humans.
    Crump KS; Chen C; Fox JF; Van Landingham C; Subramaniam R
    Ann Occup Hyg; 2008 Aug; 52(6):481-95. PubMed ID: 18628253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset.
    Conolly RB; Kimbell JS; Janszen D; Schlosser PM; Kalisak D; Preston J; Miller FJ
    Toxicol Sci; 2004 Nov; 82(1):279-96. PubMed ID: 15254341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncertainties in the CIIT model for formaldehyde-induced carcinogenicity in the rat: a limited sensitivity analysis-I.
    Subramaniam RP; Crump KS; Van Landingham C; White P; Chen C; Schlosser PM
    Risk Anal; 2007 Oct; 27(5):1237-54. PubMed ID: 18076493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat.
    Conolly RB; Kimbell JS; Janszen D; Schlosser PM; Kalisak D; Preston J; Miller FJ
    Toxicol Sci; 2003 Oct; 75(2):432-47. PubMed ID: 12857938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose response for formaldehyde-induced cytotoxicity in the human respiratory tract.
    Conolly RB; Kimbell JS; Janszen DB; Miller FJ
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):32-43. PubMed ID: 11846634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mis-specified and non-robust mortality risk models for nasopharyngeal cancer in the National Cancer Institute formaldehyde worker cohort study.
    Marsh GM; Youk AO; Morfeld P
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):59-67. PubMed ID: 17000042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled formaldehyde: evaluation of sensory irritation in relation to carcinogenicity.
    Arts JH; Rennen MA; de Heer C
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):144-60. PubMed ID: 16413643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of formaldehyde: applications of a model for the arrest of DNA replication by DNA-protein cross-links.
    Heck H; Casanova M
    Toxicol Appl Pharmacol; 1999 Oct; 160(1):86-100. PubMed ID: 10502505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled formaldehyde: exposure estimation, hazard characterization, and exposure-response analysis.
    Liteplo RG; Meek ME
    J Toxicol Environ Health B Crit Rev; 2003; 6(1):85-114. PubMed ID: 12587255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formaldehyde and glutaraldehyde and nasal cytotoxicity: case study within the context of the 2006 IPCS Human Framework for the Analysis of a cancer mode of action for humans.
    McGregor D; Bolt H; Cogliano V; Richter-Reichhelm HB
    Crit Rev Toxicol; 2006; 36(10):821-35. PubMed ID: 17118731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian analysis of a rat formaldehyde DNA-protein cross-link model.
    Yang Y; Allen BC; Tan YM; Liao KH; Clewell HJ
    J Toxicol Environ Health A; 2010; 73(12):787-806. PubMed ID: 20391121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updating the biologically based dose-response model for the nasal carcinogenicity of inhaled formaldehyde in the F344 rat.
    Conolly RB; Schroeter J; Kimbell JS; Clewell H; Andersen ME; Gentry PR
    Toxicol Sci; 2023 May; 193(1):1-17. PubMed ID: 36912747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of carcinogenicity of formaldehyde based on the newest literature data].
    Kupczewska-Dobecka M
    Med Pr; 2007; 58(6):527-39. PubMed ID: 18421935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the cancer potential of methanol.
    Cruzan G
    Crit Rev Toxicol; 2009; 39(4):347-63. PubMed ID: 19514918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-stage models of tumor incidence for historical control animals in the National Toxicology Program's carcinogenicity experiments.
    Portier CJ; Bailer AJ
    J Toxicol Environ Health; 1989; 27(1):21-45. PubMed ID: 2724366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waterborne adenovirus.
    Mena KD; Gerba CP
    Rev Environ Contam Toxicol; 2009; 198():133-67. PubMed ID: 19253037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses.
    Schlosser PM; Lilly PD; Conolly RB; Janszen DB; Kimbell JS
    Risk Anal; 2003 Jun; 23(3):473-87. PubMed ID: 12836840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer simulation of cell growth governed by stochastic processes: application to clonal growth cancer models.
    Conolly RB; Kimbell JS
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):284-95. PubMed ID: 8122275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.